Pharma Pulse 2/28/25: Delivering Personalized Experiences at Scale, Combat Counterfeit Medications & more

Delivering Personalized Experiences at Scale: A Fresh Look at Customer Centricity

Customer centricity. An overused buzzword in the life sciences industry. Yet an important goal. In an era of eroding rep access, fragmented channels and growing complexity in treatment decisions, building a customer-centric commercial operation is more difficult than ever.

Combat Counterfeit Medications

When educating patients, emphasize the importance of buying drugs from only licensed pharmacies.

HHS Lays Off Lawyers Who Were Defending Medicare Drug Price Cuts

At least three government lawyers working on defending a major Biden-era drug pricing law were laid off in mass cuts across the agency this month, according to a source familiar with the terminations.

HighByte Launches API Builder for Industrial Data

HighByte announced the release of HighByte Intelligence Hub version 4.1 with Callable Pipelines. Callable Pipelines, together with the REST Data Server, functionally serve as an “Industrial Data API Builder” that allows users to build custom API endpoints to interact with industrial data. In addition to Pipelines enhancements, version 4.1 delivers native integration with Aspen InfoPlus.21, support for the new Amazon S3 Tables service, granular audit logging for regulated industries, and seamless event capture from file-based data sources.

Cencora | Pharma solutions on LinkedIn

Listen in as Jenna Dale, MBA, Director of Client Relations, shares more on the challenges associated with meeting the FDA’s 2025 cell and gene therapy forecasted approval goal, emphasizes the progress being made, and offers advice for all stakeholders on how pharma can collectively work together to reach that goal.
#CGT #cellandgenetherapy

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs